New England Journal of Medicine Retracts Amgen Drug Trial Paper Amid Data Integrity Concerns
The New England Journal of Medicine (NEJM) has retracted a significant clinical trial paper that provided support for Amgen’s drug Tavneos. The retraction comes after concerns were raised regarding the integrity of the patient outcome data used in the study, with allegations that the data may have been altered and that some researchers involved in […]